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Copper(II) complexes of functionalized 2,2’:6’,2’’-
terpyridines and 2,6-di(thiazol-2-yl)pyridine:
structure, spectroscopy, cytotoxicity and catalytic
activity†
Katarzyna Czerwińska, a Barbara Machura, *a Slawomir Kula, b
Stanisław Krompiec,b Karol Erfurt,c Catarina Roma-Rodrigues,d
Alexandra R. Fernandes,*d Lidia S. Shul’pina, e Nikolay S. Ikonnikove and
Georgiy B. Shul’pin *f,g
Six new copper(II) complexes with 2,2’:6’,2’’-terpyridine (4’-Rn-terpy) [1 (R1 = furan-2-yl), 2 (R2 = thio-
phen-2-yl), and 3 (R3 = 1-methyl-1H-pyrrol-2-yl)] and 2,6-di(thiazol-2-yl)pyridine derivatives (Rn-dtpy)
[4 (R1), 5 (R2), and 6 (R3)] have been synthesized by a reaction between copper(II) chloride and the corres-
ponding ligand. The complexes have been characterized by UV-vis and IR spectroscopy, and their struc-
tures have been determined by X-ray analysis. The antiproliferative potential of copper(II) complexes of
2,2’:6’,2’’-terpyridine and 2,6-di(thiazol-2-yl)pyridine derivatives towards human colorectal (HCT116) and
ovarian (A2780) carcinoma as well as towards lung (A549) and breast adenocarcinoma (MCF7) cell lines
was examined. Complex 1 and complex 6 were found to have the highest antiproliferative eﬀect on
A2780 ovarian carcinoma cells, particularly when compared with complex 2, 3 with no antiproliferative
eﬀect. The order of cytotoxicity in this cell line is 6 > 1 > 5 > 4 > 2 ≈ 3. Complex 2 seems to be much
more speciﬁc towards colorectal carcinoma HCT116 and lung adenocarcinoma A549 cells. The viability
loss induced by the complexes agrees with Hoechst 33258 staining and typical morphological apoptotic
characteristics like chromatin condensation and nuclear fragmentation. The speciﬁcity towards diﬀerent
types of cell lines and the low cytotoxic activity towards healthy cells are of particular interest and are a
positive feature for further developments. Complexes 1–6 were also tested in the oxidation of alkanes
and alcohols with hydrogen peroxide and tert-butyl-hydroperoxide (TBHP). The most active catalyst 4
gave, after 120 min, 0.105 M of cyclohexanol + cyclohexanone after reduction with PPh3. This concen-
tration corresponds to a yield of 23% and TON = 210. Oxidation of cis-1,2-dimethylcyclohexane with
m-CPBA catalyzed by 4 in the presence of HNO3 gave a product of a stereoselective reaction (trans/cis =
0.47). Oxidation of secondary alcohols aﬀorded the target ketones in yields up to 98% and TON = 630.
Introduction
Transition metal complexes of 4′-functionalized 2,2′:6′,2″-
terpyridines have attracted widespread scientific attention in
view of their interesting electronic, photonic, magnetic, reac-
tive and structural properties,1 as well as promising appli-
cations in catalysis,2 molecular magnetism,3 molecular elec-
tronics,4 supramolecular chemistry5 and anti-tumor therapy.6
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Substituents in 2,2′:6′,2″-terpyridines and 2,6-di(thiazol-2-yl)-
pyridines are utilized to tailor the electronic properties of the
ligand and its metal complexes, as well as to incorporate new
functionalities using further derivatisation reactions. For
metal ion based drugs, the ligand nature is of great impor-
tance in the binding of the complex to a biomolecule such as
DNA or protein. The chelating ability of 2,2′:6′,2″-terpyridine
enhances the stability of the metal complex, and planarity of
the ligand leads to strong intercalative interaction of the
complex with DNA.7
In the field of anticancer drug design, special attention has
been devoted to copper(II) complexes with 2,2′:6′,2″-terpyri-
dines owing to the bio-essential nature of Cu(II) ions. Studies
revealed that these complexes are able to promote the gene-
ration of reactive oxygen species (ROS) in the presence of mild
reducing agents, which has been exploited to oxidatively break
the DNA strands and further to inhibit the proliferation of
tumor cells.8 In the recent past, 2,2′:6′,2″-terpyridine-based
copper(II) complexes have also found remarkable applications
as catalysts for the aerobic oxidation of alcohols under mild
conditions.9
Herein, three functionalized 2,2′:6′,2″-terpyridines and
three 2,6-di(thiazol-2-yl)pyridines were used to generate copper(II)
complexes (Schemes 1 and 2), and their cytotoxicity as well as
catalytic activity in the oxidation of alkanes and alcohols
were investigated. Interestingly, 2,6-di(thiazol-2-yl)pyridine
derivatives, considered to be 2,2′:6′,2″-terpyridine analogues,
have received far less attention compared to 2,2′:6′,2″-terpyri-
dine derivatives. Although a thiazole ring is related to pyridine
in its aromaticity and general chemistry, it diﬀers in electronic
properties. To the best of our knowledge, only a few transition
metal complexes of 2,6-di(thiazol-2-yl)pyridines have been
reported so far.10 The known in the literature11 complex
[CuCl2(terpy)] with an unsubstituted terpyridine has been syn-
thesized and investigated here for comparison with other sub-
stituted compounds.
Results and discussion
Synthesis and general characterization of the complexes
2,2′:6′,2″-Terpyridine and 2,6-di(thiazol-2-yl)pyridine deriva-
tives were obtained by condensation of the corresponding
aldehyde with 2-acetylpyridine and 2-acetylthiazole, respect-
ively, as shown in Scheme 2. The first step of a base-mediated
Kröhnke condensation is not isolated, but undergoes in situ
pyridine ring closure performed in the presence of an
ammonia source.12
The copper complexes were isolated as green solids by the
reaction of a methanol solution of the appropriate ligand with
a methanolic solution of CuCl2·2H2O. In the IR spectra, the
characteristic bands assignable to ν(CvC) and ν(CvN)
vibrations of coordinated N-heterocyclic ligands are observed
in the range 1615–1526 cm−1 (see Fig. S3 in the ESI†).
Compared to the free ligands, they are slightly shifted towards
higher wavenumbers.
The electronic reflectance spectra of the examined copper(II)
compounds (Fig. 1) are characterized by a very broad asym-
metric band in the region 600–1000 nm typical for overlapping
dxy → dx2−y2, dyz, dxz → dx2−y2 and dz2 → dx2−y2 transitions
between d orbitals of the coordinated copper(II) ion.13 A collec-
tion of bands below 400 nm are attributed to triimine-centred
π→ π* and n→ π* excitations (see also Fig. S2†).
Molecular structures
Perspective views of the asymmetric units of 1–6 are shown in
Fig. 2. The selected bond distances and bond angles were
included in ESI (Table S2†).
The crystal structure of 1 is composed of mononuclear
units [CuCl2(R
1-terpy)] and co-crystallised methanol molecules,
while the structure of 3 comprises two independent molecules
per asymmetric unit (Fig. 2). The independent complex mole-
cules with Cu(1) and Cu(2) centres are five coordinated by
three nitrogen atoms of the tridentate coordinated R3-terpy
molecule and two chloride ions, but they diﬀer noticeably in
the geometry around the metal center. The angular structural
index parameters τ 14 of 0.077 for molecule A and 0.457 for
B ion indicate that the geometry of the metal centres Cu(1)
and Cu(2) may be described as a distorted square-pyramid and
an intermediate between a trigonal bipyramid and a square-
pyramid, respectively. The distortion of the coordination
sphere of Cu(1) and Cu(2) ions in 3 from ideal five-vertex poly-
hedra (square-pyramid and trigonal bipyramid) was also calcu-
Scheme 1 The substituted 2,2’:6’,2’’-terpyridine (Rn-terpy) and 2,6-
di(thiazol-2-yl)pyridine (Rn-dtpy) ligands prepared in this work, as well
as copper complexes bearing these ligands.
Scheme 2 The synthetic route to 2,2’:6’,2’’-terpyridine (Rn-terpy) and
2,6-di(thiazol-2-yl)pyridine derivatives (Rn-dtpy).
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lated using the SHAPE program15 based on the Continuous
Shape Measures (CShM) concept.16
SQðPÞ ¼ min
Pn
i¼1
~qi ~pij j2
Pn
i¼1
~qi ~q0j j2
2
664
3
775 100
As seen in Table 1, the calculated values of SQ(TBY) and
SQ(SPY) confirm that the coordination polyhedron of the Cu(1)
ion is a square-pyramid, while the geometry around the Cu(2)
center seems to be much closer to a trigonal bipyramid. In the
other complexes examined herein, the metal center is in a
square pyramid environment. It is noteworthy that the trigo-
nal–bipyramidal geometry in the five-coordinate Cu(II) com-
plexes incorporating 2,2′:6′,2″-terpyridines of general formula
[CuCl2(R-terpy)] is rather unusual. These compounds definitely
prefer a square pyramidal geometry. CSD (Cambridge
Structural Database, Version 5.37)17 searches revealed only
three complexes [CuCl2(R-terpy)] which show a geometry closer
Fig. 1 The solid state absorption UV-Vis spectra of the free ligands (Rn-terpy and Rn-dtpy) and Cu(II) complexes (1–6).
Fig. 2 Perspective views showing the asymmetric unit of 1 (a), 2 (b), 3 (c), 4 (d), 5 (e) and 6 (f ) with the atom numbering. Displacement ellipsoids are
drawn at the 50% probability level.
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to a trigonal bipyramid, while 16 structures can be described
as a distorted square-pyramid (see Table S1†). The occurrence
of a trigonal bipyramidal geometry in the case of 3 seems to be
attributed to the presence of the bulky methyl substituent.
Typically for the square-pyramidal configuration, due to
Jahn–Teller distortion,18 the Cu–Cl apical bond in 1–6 is much
longer than the Cu–Cl basal bond. The significant elongation
of the Cu(1)–Cl(2) bond in 1 compared to the other complexes
may be attributed to the formation of the hydrogen bond O(2)–
H(2A)⋯Cl(2) [D⋯A distance = 3.195(3) Å and D–H⋯A angle =
170.10°] between the uncoordinated methanol molecules and
[CuCl2(R
1-terpy)]. As can be expected, a smaller diﬀerence
between the apical and equatorial Cu–Cl bond lengths was
observed for molecule B of 3.
In all the complexes, the 2,2′:6′,2″-terpyridine and 2,6-
di(thiazol-2-yl)pyridine skeletons are approximately planar.
The maximum value of the dihedral angle between the mean
planes of the terminal aromatic rings is 11.7° in complex 2.
The twisting of the R-substituent plane relative to the central
pyridine ring assumes values from 4.0° (in 4) to 19.10° (in the
A molecule of 3) (Table S3†). The two outer nitrogen atoms
N(1) and N(2) form longer Cu–N bonds (1: 2.042(2) Å and
2.045(2) Å; 2: 2.036(4) Å and 2.050(4) Å; 3A: 2.043(2) Å and
2.051(2) Å; 3B: 2.017(2) Å and 2.023(2) Å; 4: 2.036(2) Å and
2.046(2) Å; 5: 2.046(3) Å and 2.047(3) Å; 6: 2.027(4) Å and
2.048(4) Å) than the central nitrogen atom (1: 1.941(2) Å;
2: 1.939(3) Å; 3A: 1.950(2) Å; 3B: 1.955(2) Å; 4: 1.976(2) Å;
5: 1.977(2) Å; 6: 1.979(4) Å). The same geometry and pattern of
bond distances have been observed in most terpy complexes with
copper(II) (Table S1†) or other divalent transition-metal ions.13
The crystal packing analysis (Mercury 2.4 program)19
revealed that the dominant driving forces towards self-aggrega-
tion of molecules [CuCl2(R
n-terpy)] and [CuCl2(R
n-dtpy)] in the
structures of 1–6 are weak hydrogen bonds C–H⋯Cl,
(Table S4†) as well as π⋯π (Table S5†) and π⋯Cl (Table S6†)
interactions. The R1-terpy domains in 1 and Rn-dtpy moieties
in 4 and 5 form layers, while molecules of 2, 3 and 6 are
packed into columns (Fig. 3 and Fig. S1†).
Cytotoxic potential
The in vitro antiproliferative activities of complexes 1–6 were
analysed in four human tumour cell lines, HCT116, A2780,
A549 and MCF7, by the application of the MTS colorimetric
assay. This methodology relies on the reduction of MTS into a
brownish formazan product by the mitochondrial dehydrogen-
ases in metabolically active, viable cells.20a,b A decrease of the
cell viability in a dose-dependent manner was observed for the
four tumour cell lines after 48 h exposure to complexes 1–6
(Fig. 4).
In Table 2 the IC50 values for complexes 1–6 in tumour and
normal cell lines are presented (at 48 h). The selectivity index
was calculated for A2780 towards fibroblasts. As expected, the
selectivity index is very high for complex 1, indicating that
Table 1 Distortion of the coordination sphere of ions from ideal ﬁve-
vertex polyhedra (square-pyramid (SPY) and trigonal bipyramid (TBY))
expressed as the angular structural index parameter τ 14 and calculated
using the SHAPE program15
Compound τ SQ(TBY) SQ(SPY)
1 0.132 6.296 1.626
2 0.072 5.697 1.712
3 0.077 (for Cu(1)) 5.692 (for Cu(1)) 1.611 (for Cu(1))
0.457 (for Cu(2)) 2.488 (for Cu(2)) 3.940 (for Cu(2))
4 0.080 5.866 1.465
5 0.121 5.620 1.493
6 0.059 5.928 1.886
SQ(TBY) – distortion of the coordination sphere of the Cu ion from
ideal trigonal bipyramid. SQ(SPY) – distortion of the coordination
sphere of the Cu ion from ideal square pyramid.
Fig. 3 View of the supramolecular packing of 3 (a) and 5 (b) arising from hydrogen bonds and weak π⋯π and π⋯Cl type interactions. For all struc-
tures of 1–6 see Fig. S1 of the ESI.†
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complex 1 is 20 times more selective for A2780 compared with
normal human fibroblasts.
It is noteworthy that 2,6-di(thiazol-2-yl)pyridine derivatives
(Rn-dtpy) (complexes 4, 5 and 6) demonstrate high specificity
towards ovarian carcinoma cells (A2780), particularly with the
R3-substituent (Scheme 1, Table 2 and Fig. 4d–f ) with moder-
ate to low cytotoxicity for the other three cell lines (HCT116,
A549 and MCF7). Interestingly, compared with the 2,2′:6′,2″-
terpyridine (4′-Rn-terpy) complexes only complex 1 with the R1-
substituent demonstrates the same high specificity towards
ovarian carcinoma cells (Scheme 1, Table 2 and Fig. 4a). This
indicates that most of its cytotoxic eﬀect in the ovarian carci-
noma cell line can be correlated with the presence of the R1-
substituent in complex 1. Indeed, complexes 2 and 3 (with R2-
Fig. 4 Cytotoxicity of compounds 1–6 (a–f ) in HCT116, A2780, A549 and MCF7 cell lines. HCT116 (black bars), A2780 (dark grey), A549 (light grey)
and MCF7 (white bars) cells were treated with increasing concentrations of the complex for 48 h and cell viability was determined by the MTS assay.
The data were normalized against the control treated with 0.1% (v/v) DMSO. The results shown are expressed as the mean ± SEM from three inde-
pendent assays. The asterisk (*) in the ﬁgure means that the results are statistically signiﬁcant with a p < 0.05 (as compared to the control for each
cell line).
Table 2 The relative IC50 values for complexes 1–6 in tumour and normal cell lines (at 48 h)
Cell line
Relative IC50 (µM)
Complex 1 Complex 2 Complex 3 Complex 4 Complex 5 Complex 6
HCT116 17.3 ± 0.3 2.1 ± 0.1 >100 81.7 ± 0.3 20.5 ± 0.4 >100
A2780 2.9 ± 0.1 >100 >100 5.9 ± 0.1 4.6 ± 0.1 2.6 ± 0.1
A549 20.5 ± 0.2 4.2 ± 0.2 >100 64.3 ± 0.3 22.6 ± 0.3 70.1 ± 0.4
MCF7 43 ± 0.3 >100 >100 >100 62.3 ± 0.5 89 ± 0.5
Fibroblasts 59.5 ± 0.5 >100 >100 >100 23.4 ± 0.2 >100
Selectivity index 20.5 — — — 5 —
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and R3-substituents, respectively) do not show any antiproli-
ferative activity in the ovarian carcinoma (A2780) cell line
(Scheme 1, Table 2 and Fig. 4b–c). The IC50 values (Table 2)
demonstrate that complex 2 (with the R2-substituent) seems to
be highly specific towards colorectal carcinoma (HCT116) and
lung adenocarcinoma (A549) cells (Table 2 and Fig. 4b). Of
relevance is the fact that the trigonal bipyramidal geometry in
the case of 3 (attributed to the presence of the bulky methyl
substituent) instead of the more common square pyramidal
one (other Cu(II) complexes) does not show any cytotoxic
activity in tumour cell lines (Fig. 4c and Table 2).
Except for complex 5 that shows moderate activity towards
normal human fibroblasts, the other complexes 1–4 and 6 do
not exhibit an antiproliferative activity against normal human
Fig. 5 Cytotoxicity of complexes 1–6 in normal human ﬁbroblasts. Fibroblasts were treated with increasing concentrations of complexes 1 (black),
2 (very dark grey), 3 (dark grey), 4 (grey), 5 (light grey) and 6 (white) for 48 h and cell viability was determined by the MTS assay. The data were nor-
malized against the control treated only with 0.1% (v/v) DMSO. The results shown are expressed as the mean ± SEM from three independent assays.
The asterisk (*) in the ﬁgure means that the results are statistically signiﬁcant with a p < 0.05 (as compared to the control for each complex).
Fig. 6 Apoptotic morphological changes in A2780 cells exposed to complexes 1, 4, 5 and 6. A. Hoechst staining of the A2780 cell line for the visual-
ization of apoptotic nuclei (excitation and ﬂuorescence emission spectra at 352/461 nm, respectively). Cells were grown in DMEM culture medium
supplemented with 10% foetal bovine serum in the presence of (A1) 0.1% DMSO (control), (A2) the IC50 of complex 4, (A3) the IC50 of complex 5,
(A4) the IC50 of complex 1, and (A5) the IC50 of complex 6 for 48 h and stained with Hoechst 33258. Plates were photographed on an AXIO Scope
(Carl Zeiss, Oberkochen, Germany). Typical morphological features of apoptosis like chromatin condensation and nuclear fragmentation are ident-
iﬁed (green arrows). B. The value in % of apoptotic cells after exposure of A2780 cells to the control vehicle (DMSO) or complexes 4, 5, 1 and 6.
Three random microscopic ﬁelds per sample with ca. 50 nuclei were counted. *p-Value <0.05 relative to apoptosis in cells incubated with DMSO.
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fibroblasts at the concentrations tested (IC50 higher than
50 µM) (see Fig. 5 and Table 2).
Cytoreductive surgery plus platinum based chemotherapy is
the first line of treatment in ovarian cancer, but due to chemo-
resistance, this therapy has limited eﬃcacy.20c In this regard,
to compare the eﬀect of our complexes with that of cisplatin
on ovarian carcinoma cells we have studied under the same
experimental conditions the eﬀect of cisplatin on A2780 cell
viability (ESI Fig. 6†). The relative IC50 observed for cisplatin is
3.4 ± 0.2 μM, which is similar to the IC50 observed for com-
plexes 1, 4, 5 and 6 (Table 2). Indeed, compared to cisplatin,
complexes 1 and 6 show a higher cytotoxicity towards the
A2780 cell line, demonstrating their promising eﬀect, which
should be considered in further biological studies.
Apoptotic potential
The reduction of cell viability promoted by complexes 1–6 in
A2780 cells (Fig. 4c) prompted us to evaluate the underlying
mechanisms of cell death. A preliminary analysis was per-
formed by staining using Hoechst 33258 dye owing to its high
aﬃnity for DNA allowing the detection of nuclear alterations
like chromatin condensation and nuclear fragmentation,
typical features of apoptotic cells.21 Hoechst 33258 staining of
A2780 cells after 48 h of exposure to the IC50 of each relevant
complex allowed us to observe a reduction in the number of
stained cells compared to control cells and the nuclear con-
densation and fragmentation characteristics of apoptosis
(Fig. 6). Hoechst 33258 staining of HCT116 cells after 48 h of
exposure to the IC50 of complex 2 is also shown in Fig. 6. As we
can observe (Fig. 6 and 7) the induction of apoptosis totally
agrees with the viability results presented before.
Catalytic oxidation of alkanes and alcohols with peroxides
Copper ions constitute the reaction centres of some alcohol-
and alkane-oxidizing enzymes.22 Copper complexes are known
to catalyze the oxygenation of alkanes into alkyl hydroper-
oxides23 and oxidize alcohols into the corresponding ketones
(aldehydes).9a,24 Molecular oxygen and various peroxides
(H2O2, tert-butyl hydroperoxide, peroxyacetic acid, meta-chloro-
peroxybenzoic acid) were used as oxidants.
As has been mentioned above, the oxygenation of saturated
hydrocarbons such as RH, as well as of some alkane deriva-
tives with H2O2, usually gives rise to the formation of the
corresponding alkyl hydroperoxides, ROOH, as the main
primary products. We use a simple method developed earlier
by one of us25 to demonstrate the formation of alkyl hydroper-
oxide in this oxidation and to estimate its concentration in the
course of the reaction. If an excess of solid PPh3 is added to
the sample of the reaction solution before the GC analysis, the
alkyl hydroperoxide present is completely reduced to the
corresponding alcohol. Comparing the measured by GC con-
centrations of the alcohol and ketone before and after
reduction with PPh3, we can estimate the real concentrations
of the three products (alkyl hydroperoxide, ketone and
alcohol) present in the reaction solution. In many experiments
we determined the concentrations of isomers only after
reduction with PPh3.
Two examples of cyclohexane oxidation with H2O2 catalyzed
by complexes 4 and [CuCl2(terpy)] are shown in Fig. 8. The
most active catalyst 4 gave, after 120 min, 0.105 M of cyclohexa-
nol + cyclohexanone after reduction with PPh3. This concen-
Fig. 7 Apoptotic morphological changes in HCT116 cells exposed to
complex 2. A. Hoechst staining of the HCT116 cell line for the visualiza-
tion of apoptotic nuclei (excitation and ﬂuorescence emission spectra at
352/461 nm, respectively). Cells were grown in DMEM culture medium
supplemented with 10% foetal bovine serum in the presence of (A1)
0.1% DMSO (control) and (A2) the IC50 of complex 2 for 48 h and
stained with Hoechst 33258. Plates were photographed on an AXIO
Scope (Carl Zeiss, Oberkochen, Germany). Typical morphological fea-
tures of apoptosis like chromatin condensation and nuclear fragmenta-
tion are identiﬁed (green arrows). B. The value in % of apoptotic cells
after exposure of HCT116 cells to the control vehicle (DMSO) or
complex 2. Three random microscopic ﬁelds per sample with ca. 50
nuclei were counted. *p-Value <0.05 relative to apoptosis in cells incu-
bated with DMSO.
Fig. 8 Accumulation of cyclohexanol (curves 1) and cyclohexanone
(curves 2) in the oxidation of cyclohexane (0.46 M) with H2O2 (2.0 M)
catalyzed by compound 4 (Graph A) or [Cu(terpy)Cl2] (Graph B), concen-
trations 5 × 10−4 M in acetonitrile solution at 60 °C. Curves 1a and 2a
correspond to the experiments with the addition of HNO3 (0.05 M).
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tration corresponds to a yield of 23% and TON = 210. Fig. 9
shows that in the cyclohexane oxidation with H2O2 catalyzed
by complex 2 the alcohol/ketone ratio is dramatically changed
when a reducing agent is added. This ratio is diﬀerent for
PPh3 and thiourea as reductants, which indicates the for-
mation of alkyl hydroperoxides in this reaction.
It can be clearly seen in Fig. 8 and 9 that the oxidation
occurs with auto-acceleration. This phenomenon testifies that
in the beginning of the reaction the starting complex is rather
slowly transformed into a catalytically active form. Table 3
compares the activities of the complexes after 120 min. The
complexes exhibit diﬀerent activities in cyclohexane oxidation.
In order to determine the nature of the alkane-oxidizing
species, we measured the selectivity parameters in the oxi-
dations of certain alkanes with H2O2 catalyzed by complex 4.
The selectivity parameter (1.0 : 6.0 : 5.6 : 4.7) is similar to the
selectivity parameters determined previously for systems gen-
erating free hydroxyl radicals.26 Catalyzed by 4, hydrogen per-
oxide oxidation of cis-1,2-dimethylcyclohexane gave tert-
alcohols with a 0.8 ratio of isomers with mutual trans- and cis-
orientation of methyl groups. These data indicate that the oxi-
dation proceeds with the participation of free hydroxyl
radicals.26 Oxidation of 1,2-dimethylcyclohexane with m-CPBA
catalyzed by 4 in the presence of HNO3 gave a product of a
stereoselective reaction (trans/cis = 0.47). However, this para-
meter has been found to be trans/cis = 0.8 for the catalysis by 4
in the absence of HNO3.
We have also found that secondary alcohols can be oxidized
into ketones with hydrogen peroxide or TBHP if the copper
complexes prepared in this work are used as catalysts. Some
results are presented in Table 4. It can be seen that the yield of
the target ketones reached 98% and TON = 630.
PhCHðOHÞCH3 þ tert-BuOOHþ O2 ! PhCðvOÞCH3
Fig. 9 Accumulation of cyclohexanol (curves 1) and cyclohexanone
(curves 2) in the oxidation of cyclohexane (0.46 M) with H2O2 (1.5 M)
catalyzed by compound 2 (concentrations 5 × 10−4 M) in acetonitrile
solution at 60 °C. The samples of the reaction solution were not
reduced (graph A), reduced with PPh3 (graph B), or thiourea (graph C).
Table 3 Comparison of various copper-containing catalysts in cyclo-
hexane oxidation with H2O2
a
Entry Catalyst
Yield of
oxygenates (M)
Total
yield (%) TON
1 4 0.105 23 210
2 [Cu(terpy)Cl2] 0.059 13 118
3 5 0.057 12 114
4 3 0.044 9.6 88
5 2 0.040 8.7 80
6 6 0.023 5 46
7 1 0.008 2 16
a The yields of cyclohexanol and cyclohexanone were measured after
120 min heating at 60 °C and after reduction of the reaction samples
with PPh3.
Table 4 Alcohol oxidation with TBHP catalyzed by various copper-
containing complexesa
Entry Alcohol Catalyst T (°C)
Time
(min)
Yield
(%) TON
1 PhCH(OH)CH3 4 50 15 10
2 PhCH(OH)CH3 4 50 120 39
3 PhCH(OH)CH3 4 50 300 51
4 PhCH(OH)CH3 4 50 480 80 520
5 PhCH(OH)CH3 4 60 90 56
6 PhCH(OH)CH3 4 60 180 82
7 PhCH(OH)CH3 4 60 300 94 620
8 PhCH(OH)CH3 4 60 90 56
9 PhCH(OH)CH3 4 60 180 82
10 PhCH(OH)CH3 4 60 300 98 630
11 Cyclohexanol 3 60 60 39
12 Cyclohexanol 3 60 180 39
13 Cyclohexanol 3 60 300 40 344
14 Cyclohexanol 3 60 480 43
15 Cyclohexanol 2 60 60 39
16 Cyclohexanol 2 60 180 49
17 Cyclohexanol 2 60 300 56
18 Cyclohexanol 2 60 480 65 520
19 Cyclohexanol 4 60 60 48
20 Cyclohexanol 4 60 180 60
21 Cyclohexanol 4 60 330 71 580
a The yields of cyclohexanol and cyclohexanone were measured after
120 min heating at 60 °C and after reduction of the reaction samples
with PPh3.
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Conclusions
Six new copper(II) complexes incorporating 2,2′:6′,2″-terpyridine
and 2,6-di(thiazol-2-yl)pyridine-based ligands have been syn-
thesized and characterized. Two applied studies of these com-
plexes were conducted. Thus, the antiproliferative potential of
the copper(II) complexes of 2,2′:6′,2″-terpyridine (Rn-terpy) and
2,6-di(thiazol-2-yl)pyridine (Rn-dtpy) derivatives was examined
towards human colorectal (HCT116) and ovarian (A2780) carci-
noma as well as towards lung (A549) and breast adeno-
carcinoma (MCF7) cell lines. Complex 1 and complex 6 were
found to have the highest antiproliferative eﬀect on A2780
ovarian carcinoma cells, particularly when compared with
complexes 2 and 3 with no antiproliferative eﬀect. The order of
cytotoxicity in this cell line is 6 > 1 > 5 > 4 > 2 ≈ 3. Complex 2
seems to be much more specific towards colorectal carcinoma
HCT116 and lung adenocarcinoma A549 cells. The viability
loss induced by the complexes was in agreement with Hoechst
33258 staining and typical morphological apoptotic character-
istics like chromatin condensation and nuclear fragmentation.
The specificity, towards diﬀerent types of cell lines, of these
2,2′:6′,2″-terpyridine (Rn-terpy) and 2,6-di(thiazol-2-yl)pyridine
(Rn-dtpy) derivatives and their low cytotoxic activity towards
healthy cells are of particular interest and are a positive feature
for further developments. These complexes exhibited diﬀerent
catalytic activities in the oxidation of alkanes and alcohols
with peroxides.
Experimental
Materials
All the solvents used in the synthesis were of reagent grade
and were used as received. The salt CuCl2·2H2O used in the
synthesis was commercially available and was used without
further purification. 4′-Functionalized 2,2′:6′,2″-terpyridine
and 2,6-di(thiazol-2-yl)pyridine derivatives were prepared
according to a literature method.4b,10c,12,27
Instrumentation
The IR spectra were recorded on a Nicolet iS5 spectrophoto-
meter in the spectral range 4000–400 cm−1 with samples in
the form of KBr pellets. The electronic spectra were obtained
using a Nicolet Evolution 220 in the ranges of 210–1000 nm in
methanol (see the ESI†) and 190–1100 nm in solid state
samples. Powder X-ray diﬀraction (PXRD) measurements were
performed on a PANalytical Empyrean X-ray diﬀractometer
using Cu-Kα radiation (λ = 1.5418 Å), in which the X-ray tube
was operated at 40 kV and 30 mA in the range of 0 to 50°.
The X-ray diﬀraction data were collected on an Oxford
Diﬀraction four-circle diﬀractometer Gemini A Ultra equipped
with an Atlas CCD detector using graphite monochromated
Mo Kα radiation (λ = 0.71073 Å) at room temperature. Details
of crystal data and refinement are given in Table 5. Lorentz,
polarization and empirical absorption corrections using
spherical harmonics implemented in the SCALE3 ABSPACK
scaling algorithm28 were applied. The structures were solved
by the Patterson method using SHELXS97 and refined by full-
matrix least-squares on F2 using SHELXL97.29 All the non-
hydrogen atoms were refined anisotropically, and hydrogen
atoms were placed at calculated positions refined using ideal-
ized geometries (riding model) and assigned fixed isotropic
displacement parameters, d(C–H) = 0.93 Å, Uiso(H) = 1.2Ueq(C).
Synthesis of the complexes
General synthesis route for [CuCl2(R
n-terpy)] (1–3),
[CuCl2(R
n-dtpy)] (4–6) and [CuCl2(terpy)]. The salt CuCl2·2H2O
(0.17 g, 1 mmol) dissolved in methanol (10 ml) was added
dropwise to hot methanolic solutions of Rn-terpy, Rn-dtpy or
terpy (1 mmol). The resulting solution was stirred at room
temperature for 2 h and after a few days green crystalline
solids were obtained. Crystals suitable for X-ray investigation
were obtained by recrystallization from methanol or
acetonitrile.
[CuCl2(R
1-terpy)] (1). Yield 64%. HRMS (ESI): calcd for
C19H13ClCuN3O
+ 397.0043 found 397.0055. IR (KBr, cm−1):
1615(s), 1583(m) 1560(m), 1475(s), 1435(m), 1385(w), 1304(m),
1255(m), 1235(w), 1157(w), 1027(s), 1019(s), 883(m), 793(s),
751(m), 741(m), 729(m), 687(m), 655(m), 645(w), 586(w).
UV-Vis (MeOH, λmax, nm (ε, dm
3 mol−1 cm−1)): 222(35 700),
261(23 700), 289(21 300), 347(31 000) and 701(131). UV-Vis
(solid, nm): 302, 319, 366 and 720.
[CuCl2(R
2-terpy)] (2). Yield 79%. HRMS (ESI): calcd for
C19H13ClCuN3S
+ 412.9815 found 412.9821. IR (KBr, cm−1):
1607(s), 1569(m), 1559(s), 1528(m), 1474(s), 1429(s), 1377(w),
1252(m), 1165(m), 1053(m), 1033(m), 1018(m), 892(w), 859(m),
793(s), 778(m), 751(m), 729(m), 702(s), 655(w), 627(m), 560(w).
UV-Vis (MeOH, λmax, nm (ε, dm
3 mol−1 cm−1)): 221(31 300),
266(20 700), 287(21 300), 347(25 300) and 701(134). UV-Vis
(solid, nm): 225, 285, 322, and 727.
[CuCl2(R
3-terpy)] (3). Yield 71%. HRMS (ESI): calcd for
C20H16ClCuN4
+ 410.0359 found 410.0359. IR (KBr, cm−1):
1610.78(s), 1568(m), 1555(m), 1534(w), 1475(s), 1431(s),
1400(m), 1302(m), 1274(m), 1255(w), 1245(m), 1156(m),
1077(m), 1066.29(w), 1030(m), 1019(m), 998(m), 792(s), 735(w),
719(m), 676(m), 646(w), 600(w). UV-Vis (MeOH, λmax, nm
(ε, dm3 mol−1 cm−1)): 220(36 900), 266(23 900), 276(21 021),
320(16 600), 389(18 900) and 701(115). UV-Vis (solid, nm): 231,
273, 317, 366 and 735.
[CuCl2(R
1-dtpy)] (4). Yield 70%. HRMS (ESI): calcd for
C15H9ClCuN3OS2
+ 408.9172 found 408.9171. IR (KBr, cm−1):
1610(s), 1578(m), 1550(m), 1489(s), 1455(s), 1437(m), 1386(m),
1355(w), 1267(w), 1240(m), 1193(s), 1148(w), 1101(w), 1063(m),
1037(m), 1020(s), 919(m), 881(m), 856(m), 786(s), 762(s),
742(s), 637(m), 596(m), 577(w). UV-Vis (MeOH, λmax, nm
(ε, dm3 mol−1 cm−1)): 276(19 700), 308(28 100), 352(31 000)
and 741(128). UV-Vis (solid, nm): 231, 297, 379 and 787.
[CuCl2(R
2-dtpy)] (5). Yield 82%. HRMS (ESI): calcd for
C15H9ClCuN3S3
+ 424.8943 found 424.8942. IR (KBr, cm−1):
1611(s), 1551(m), 1526, 1496(s), 1483(m), 1452(m), 1419(m),
1404(m), 1364(m), 1266(m), 1245(m), 1206(s), 1196(s), 1147(w),
1099(m), 1021(w), 915(m), 848(m), 787(s), 773(w), 757(w),
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740(s), 625(w), 614(m), 564(w). UV-Vis (MeOH, λmax, nm
(ε, dm3 mol−1 cm−1)): 304(20 800), 352(18 400) and 736(116).
UV-Vis (solid, nm): 295 and 802.
[CuCl2(R
3-dtpy)] (6). Yield 45%. HRMS (ESI): calcd for
C16H12ClCuN4S2
+ 421.9488 found 421.9488. IR (KBr, cm−1):
1603(s), 1599(s), 1544(m), 1536(m), 1498(m), 1481(s), 1442(m),
1417(m), 1395(s), 1351(m), 1337(m), 1292(m), 1242(m),
1206(m), 1194(m), 1074.20(s), 1020(m), 999(m), 821(w),
797(m), 787(s), 771(m), 749(s), 677(w), 638(w), 588(w). UV-Vis
(MeOH, λmax, nm (ε, dm
3 mol−1 cm−1)): 274(23 300),
300(22 100), 338(20 700), 391(15 700) and 741(110). UV-Vis
(solid, nm): 356 and 763.
Cell culture
Human colorectal (HCT116) and ovarian carcinoma (A2780)
cell lines and the lung adenocarcinoma (A549) cell line were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen Corp., Grand Island, NY, USA) supplemented with
10% fetal bovine serum and 1% antibiotic/antimycotic solu-
tion (Invitrogen Corp.) and maintained at 37 °C under a
humidified atmosphere of 5% (v/v) CO2.
30 MCF7 cells derived
from pleural eﬀusion of breast adenocarcinoma from a female
patient were grown under similar conditions, supplemented
with 1% MEM non-essential amino acids (Invitrogen Corp.).30
Normal human fibroblasts were grown under the same con-
ditions as the MCF7 cell line31 All cell lines were purchased
from ATCC (http://www.atcc.org) with the exception of A2780
that was purchased from Sigma-Aldrich (http://www.sigmaal-
drich.com).
Compound exposure for dose–response curves
Cells were plated at 5000 cells per well in 96-well plates. The
medium was removed 24 h after plating and was replaced with
a fresh medium containing: 0.1–200 µM of complexes 1–6 or
0.1% (v/v) DMSO (vehicle control). All the above solutions were
Table 5 Crystal data and structure reﬁnement of copper(II) complexes
(1) (2) (3) (4) (5) (6)
Empirical formula C20H17Cl2CuN3O2 C19H13Cl2CuN3S C20H16Cl2Cu N4 C15H9Cl2CuN3OS2 C15H9Cl2CuN3S3 C16H12Cl2CuN4S2
Formula weight 465.80 449.82 446.81 445.81 461.87 458.86
Temperature [K] 295.0(2) 295.0(2) 295.0(2) 295.0(2) 295.0(2) 295.0(2)
Wavelength [Å] 0.71073 0.71073 0.71073 0.71073 0.71073 0.71073
Crystal system Triclinic Monoclinic Triclinic Triclinic Triclinic Orthorhombic
Space group P1ˉ P21/c P1ˉ P1ˉ P1ˉ Pna21
Unit cell
dimensions [Å, °]
a = 7.9205(5) a = 7.8185(4) a = 9.3952(3) a = 7.8472(4) a = 7.8330(4) a = 21.3169(8)
b = 10.6701(6) b = 11.0960(7) b = 12.8556(4) b = 10.3540(6) b = 10.9863(8) b = 10.9680(5)
c = 12.6536(8) c = 20.4983(12) c = 16.9843(6) c = 11.2776(7) c = 11.2152(8) c = 7.5747(4)
α = 106.766(5) α = 72.580(3) α = 116.387(6) α = 118.351(7)
β = 97.488(5) β = 95.626(5) β = 81.358(3) β = 95.253(5) β = 92.578(5)
γ = 102.659(5) γ = 73.642(3) γ = 90.856(4) γ = 91.767(6)
Volume [Å3] 977.37(11) 1769.74(18) 1873.19(11) 815.80(9) 847.01(11) 1770.99(14)
Z 2 4 4 2 2 4
Density (calculated)
[Mg m−3]
1.583 1.688 1.584 1.815 1.811 1.721
Absorption
coeﬃcient [mm−1]
1.412 1.662 1.464 1.929 1.976 1.778
F(000) 474 908 908 446 462 924
Crystal size [mm] 0.28 × 0.07 × 0.05 0.22 × 0.05 × 0.02 0.16 × 0.14 × 0.09 0.36 × 0.06 × 0.03 0.50 × 0.05 × 0.03 0.55 × 0.27 × 0.07
θ range for data
collection [°]
3.32 to 25.05 3.43 to 25.05 3.30 to 25.05 3.37 to 25.05 3.36 to 25.04 3.30 to 25.05
Index ranges −9 ≤ h ≤ 9 −9 ≤ h ≤ 9 −11 ≤ h ≤ 10 −9 ≤ h ≤ 9 −9 ≤ h ≤ 9 −25 ≤ h ≤ 25
−11 ≤ k ≤ 12 −13 ≤ k ≤ 11 −15 ≤ k ≤ 14 −12 ≤ k ≤ 11 −13 ≤ k ≤ 12 −12 ≤ k ≤ 13
−14 ≤ l ≤ 15 −24 ≤ l ≤ 23 −20 ≤ l ≤ 20 −13 ≤ l ≤ 13 −13 ≤ l ≤ 12 −9 ≤ l ≤ 7
Reflections collected 8026 7539 15 611 6826 6680 7628
Independent reflections 3468
(Rint = 0.0351)
3126
(Rint = 0.0508)
6636
(Rint = 0.0338)
2888
(Rint = 0.0356)
2993
(Rint = 0.0335)
2958
(Rint = 0.0340)
Completeness to
2θ = 50° [%]
99.8 99.8 99.8 99.7 99.8 99.8
Max. and min.
transmission
1.000 and 0.747 1.000 and 0.776 1.000 and 0.805 1.000 and 0.134 1.000 and 0.752 1.000 and 0.393
Data/restraints/parameters 3468/0/255 3126/0/235 6636/0/489 2888/0/217 2993/0/217 2958/0/227
Goodness-of-fit on F2 1.012 1.040 1.034 1.039 1.025 1.038
Final R indices
[I > 2σ(I)]
R1 = 0.0369 R1 = 0.0538 R1 = 0.0354 R1 = 0.0333 R1 = 0.0359 R1 = 0.0316
wR2 = 0.0803 wR2 = 0.1323 wR2 = 0.0838 wR2 = 0.0680 wR2 = 0.0812 wR2 = 0.0683
R indices (all data) R1 = 0.0544 R1 = 0.0715 R1 = 0.0515 R1 = 0.0513 R1 = 0.0513 R1 = 0.0382
wR2 = 0.0863 wR2 = 0.1415 wR2 = 0.0900 wR2 = 0.0705 wR2 = 0.0878 wR2 = 0.0715
Largest diﬀ. peak and
hole [e Å−3]
0.271 and −0.297 1.038 and −0.583 0.383 and −0.274 0.319 and −0.377 0.475 and −0.518 0.247 and −0.352
CCDC number 1540061 1540064 1540062 1540063 1540065 1540066
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prepared from concentrated stock solutions (in DMSO) of com-
plexes 1–6.
Viability assays
After 48 h of cell incubation in the presence or absence of
complexes 1–6, cell viability was evaluated using a CellTiter
96® AQueous Non-Radioactive Cell Proliferation Assay
(Promega, Madison, WI, USA), using 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetra-
zolium, inner salt (MTS) as previously described.20 In brief,
this is a homogeneous, colorimetric method for determining
the number of viable cells in proliferation, cytotoxicity or che-
mosensitivity assays. The CellTiter 96® AQueous Assay is com-
posed of solutions of MTS and an electron coupling reagent
(phenazinemethosulfate, PMS). MTS is bioreduced by cells
into a formazan product that is soluble in a tissue culture
medium. The absorbance of the formazan product at 490 nm
can be measured directly from 96-well assay plates without
additional processing. The conversion of MTS into the
aqueous soluble formazan product is accomplished by using
dehydrogenase enzymes found in metabolically active cells.
The quantity of formazan product was measured on a Bio-Rad
microplate reader, model 680 (Bio-Rad, Hercules, CA, USA), at
490 nm, as absorbance is directly proportional to the number
of viable cells in culture.
Assessment of apoptosis through Hoechst 33258 staining
A2780 cells grown as described above were plated at 7500 cells
per ml and incubated for 48 h in a culture medium containing
each complex or 0.1% (v/v) DMSO (vehicle control). Hoechst
staining was used to detect apoptotic nuclei as previously
described.30 Briefly, the medium was removed, cells were
washed with phosphate-buﬀered saline 1× (PBS) (Invitrogen),
fixed with 4% (v/v) paraformaldehyde in PBS 1× (10 min in the
dark) and incubated with Hoechst 33258 dye (Sigma, Missouri,
USA; 5 µg ml−1 in PBS 1×) for another 10 min. After being
washed with PBS 1×, cells were mounted into 20 µL of a
PBS : glycerol (3 : 1; v/v) solution. Fluorescent nuclei were
sorted out according to the chromatin condensation degree
and characteristics. Normal nuclei showed non-condensed
chromatin uniformly distributed over the entire nucleus.
Apoptotic nuclei showed condensate or fragmented chromatin.
Some cells formed apoptotic bodies. Plates were photographed
on an AXIO Scope (Carl Zeiss, Oberkochen, Germany), and
three random microscopic fields per sample with ca. 50 nuclei
were counted. The mean values are expressed as a percentage
of apoptotic nuclei.30
Statistical analysis
All data are expressed as the mean ± SEM from at least three
independent experiments. Statistical significance was evalu-
ated using a Student’s t-test; p < 0.05 was considered statisti-
cally significant.
Catalytic oxidation of alkanes and alcohols
Typically, reactions were carried out in air in thermostated
Pyrex cylindrical vessels with vigorous stirring; the total
volume of the reaction solution was 5 mL. Catalysts were intro-
duced into the reaction solution in acetonitrile containing a
substrate and an oxidizing reagent. (CAUTION: the combi-
nation of air or molecular oxygen and peroxides with organic
compounds at elevated temperatures may be explosive!)
Samples of the reaction mixture obtained in the oxidation
of alkanes and linear alcohols were taken after certain time
intervals, and the concentrations of products were measured
using the GC method In the oxidations of alkanes and
benzene, the chromatograph-3700 (fused silica capillary
column FFAP/OV-101 20/80 w/w, 30 m × 0.2 mm × 0.3 μm;
helium as a carrier gas) was used. Attribution of peaks was
made by comparison with chromatograms of authentic
samples. Blank experiments with cyclohexane showed that in
the absence of a catalyst, no products were formed. The
samples obtained in the alkane oxidation were typically ana-
lyzed twice (before and after their treatment with PPh3 or
thiourea). This method (an excess of solid triphenylphosphine
or thiourea is added to the samples 10–15 min before the GC)
was proposed by one of us earlier25 and allows us to detect
alkyl hydroperoxides and measure also the real concentrations
of all three products (alkyl hydroperoxide, alcohol and alde-
hyde or ketone) present in the reaction solution. In order to
precisely determine the concentrations of isomeric alkanols,
samples of the reaction solutions after addition of nitro-
methane were analyzed only after reduction with PPh3.
The 1H NMR method was used for the quantification of the
acetophenone (Bruker AMX-400 instrument, 400 MHz) formed
in the oxidation of 1-phenylethanol. Added to the sample
acetone-d6 was used as a component of the solvent (in
addition to acetonitrile); 1,4-dinitrobenzene was used as a
standard. The detection and quantification of the obtained
products of the catalytic reactions were performed by measur-
ing the areas of the peaks corresponding to the methyl group
from acetophenone (2.6 ppm).
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